⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Purine SCHEMBL3157 | 0.98 | — | — | |
| Purine SCHEMBL2120547 | 0.98 | KDM4A (0.38) | — | |
| Purine SCHEMBL6421376 | 0.98 | KDM4A (0.38) | — | |
| Purine SCHEMBL29456595 | 0.98 | — | — | |
| Purine SCHEMBL311318 | 0.95 | KDM4A (0.37) | — | |
| Purine SCHEMBL6438162 | 0.95 | KDM4A (0.37) | — | |
| Purine SCHEMBL1150716 | 0.95 | KDM4A (0.37) | — | |
| Purine SCHEMBL5578775 | 0.95 | KDM4A (0.37) | — | |
| Purine SCHEMBL1389668 | 0.95 | KDM4A (0.37) | — | |
| Purine SCHEMBL9057416 | 0.95 | KDM4A (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11980630-B2 | Flex-nucleoside analogues, novel therapeutics against filoviruses and flaviviruses | UNIVERSITY OF MARYLAND, BALTIMORE COUNTY (US) | 2024-05-14 | — | — | US | disclosed |
| WO-2023245040-A1 | FLEX-NUCLEOSIDE ANALOGUES, NOVEL THERAPEUTICS AGAINST VIRUSES | UNIVERSITY OF MARYLAND, BALTIMORE COUNTY (US) | 2023-12-21 | — | — | WO | disclosed |
| WO-2023225042-A1 | FLEX-NUCLEOSIDE ANALOGUES, NOVEL THERAPEUTICS AGAINST VIRUSES | UNIVERSITY OF MARYLAND, BALTIMORE COUNTY (US) | 2023-11-23 | — | — | WO | disclosed |
| US-20220133756-A1 | FLEX-NUCLEOSIDE ANALOGUES, NOVEL THERAPEUTICS AGAINST FILOVIRUSES AND FLAVIVIRUSES | UNIV MARYLAND (US) | 2022-05-05 | — | — | US | disclosed |
| US-11253529-B2 | Flex-nucleoside analogues, novel therapeutics against filoviruses and flaviviruses | UNIVERSITY OF MARYLAND, BALTIMORE COUNTY (US) | 2022-02-22 | — | — | US | disclosed |
| US-20200171060-A1 | FLEX-NUCLEOSIDE ANALOGUES, NOVEL THERAPEUTICS AGAINST FILOVIRUSES AND FLAVIVIRUSES | UNIV MARYLAND (US) | 2020-06-04 | — | — | US | disclosed |
| US-20190201352-A1 | DESIGN, SYNTHESIS AND METHODS OF USE OF ACYCLIC FLEXMIER NUCLEOSIDE ANALOGUES HAVING ANTI-CORONAVIRUS ACTIVITY | UNIV MARYLAND (US) | 2019-07-04 | — | — | US | disclosed |
| US-10226434-B2 | Design, synthesis and methods of use of acyclic fleximer nucleoside analogues having anti-coronavirus activity | UNIVERSITY OF MARYLAND, BALTIMORE COUNTY (US) | 2019-03-12 | — | — | US | disclosed |
| WO-2019027501-A1 | FLEX-NUCLEOSIDE ANALOGUES, NOVEL THERAPEUTICS AGAINST FILOVIRUSES AND FLAVIVIRUSES | UNIVERSITY OF MARYLAND, BALTIMORE COUNTY (US) | 2019-02-07 | — | — | WO | disclosed |
| US-20180303768-A1 | DESIGN, SYNTHESIS AND METHODS OF USE OF ACYCLIC FLEXMIER NUCLEOSIDE ANALOGUES HAVING ANTI-CORONAVIRUS ACTIVITY | UNIV MARYLAND (US) | 2018-10-25 | — | — | US | disclosed |
| US-10058516-B2 | Design, synthesis and methods of use of acyclic fleximer nucleoside analogues having anti-coronavirus activity | UNIVERSITY OF MARYLAND BALTIMORE COUNTY (US) | 2018-08-28 | — | — | US | disclosed |
| US-20180015052-A1 | DESIGN, SYNTHESIS AND METHODS OF USE OF ACYCLIC FLEXMIER NUCLEOSIDE ANALOGUES HAVING ANTI-CORONAVIRUS ACTIVITY | UNIV MARYLAND (US) | 2018-01-18 | — | — | US | disclosed |
| EP-3250564-A2 | DESIGN SYNTHESIS AND METHODS OF USE OF ACYCLIC FLEXIMER NUCLEOSIDE ANALOGUES HAVING ANTI-CORONAVIRUS ACTIVITY | University of Maryland, Baltimore County (US) | 2017-12-06 | — | — | EP | disclosed |
| WO-2016123318-A2 | DESIGN SYNTHESIS AND METHODS OF USE OF ACYCLIC FLEXIMER NUCLEOSIDE ANALOGUES HAVING ANTI-CORONAVIRUS ACTIVITY | UNIVERSITY OF MARYLAND, BALTIMORE COUNTY (US) | 2016-08-04 | — | — | WO | disclosed |
| EP-0355135-B1 | ADENOSINE DEAMINASE-STABLE ANTI-RETROVIRAL NUCLEOSIDES | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1993-08-04 | — | — | EP | disclosed |
| US-4997926-A | Viricides | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1991-03-05 | — | — | US | disclosed |
| EP-0355135-A4 | ADENOSINE DEAMINASE-STABLE ANTI-RETROVIRAL NUCLEOSIDES. | SCRIPPS CLINIC RES (US) | 1990-04-09 | — | — | EP | disclosed |
| EP-0355135-A1 | ADENOSINE DEAMINASE-STABLE ANTI-RETROVIRAL NUCLEOSIDES | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1990-02-28 | — | — | EP | disclosed |
| WO-1989004662-A1 | ADENOSINE DEAMINASE-STABLE ANTI-RETROVIRAL NUCLEOSIDES | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1989-06-01 | — | — | WO | disclosed |